tirzepatide phase 2 once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, 3 trial Tirzepatide monotherapy in Chinese patients

Semaglutide has demonstrated efficacy for adults on a weight-loss journey

Risk Assessment: Evaluate the nature and extent of PHI, the unauthorized person who used/received it, whether it was actually acquired or viewed, and the extent to which the risk has been mitigated

Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients

Documentation and tracking Maintain detailed records throughout the protocol

GLP-1RAs were linked with increased bone mineral density in the lumbar spine and hip, neck, and were not associated with influenza, all-cause adverse events, or nasopharyngitis

This article was produced by the R&I Brand Studio, a unit of the advertising department of Risk & Insurance, in collaboration with Berkshire Hathaway Specialty Insurance